Business Insider

New Data Show Health Economic Benefits Of Nevro's High-Frequency Spinal Cord Stimulation Therapy

(RTTNews) - Medical device company Nevro Corp. (NVRO) Monday said new data from a study showed the health economic benefits of its 10 kHz spinal cord stimulation (SCS) therapy for the treatment of ...
Becker's ASC

Nevro Raises $58M to Prepare Spinal Cord Stimulator for U.S. Launch

Backed by the likes of Johnson & Johnson and Mayo Clinic, Nevro Corp. has raised $58 million to prepare for a hoped-for U.S. launch of its spinal cord stimulator for chronic pain, according to a ...
Becker's ASC

Nevro Receives FDA Approval to Test Spinal Cord Stimulation Device

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...
FierceBiotech

Nevro's high-frequency neurostimulation cuts diabetic neuropathy pain by 80% in 2-year study

Two years after a high-frequency version of Nevro’s neurostimulation system became the first spinal cord stimulator approved by the FDA with a specific indication to treat pain associated with ...
WDAF-TV

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain

Data Published in Journal of Neurosurgery: Spine Highlight Lasting Pain Relief, Enhanced Function, Quality of Life, and Reduced Opioid Dependency with High-Frequency SCS Therapy The published 24-month ...